[Clopidogrel and proton pump inhibitors--boon or bane?].
Labenz
J
J
Medizinische Klinik Ev. Jung-Stilling-Krankenhaus, Akademisches Lehrkrankenhaus der Universität Bonn, Wichernstr. 40, 57074 Siegen. Joachim.Labenz@diakonie-sw.de
Meyners
W
W
Petersen
K-U
KU
D000077144:Clopidogrel; D004347:Drug Interactions; D004359:Drug Therapy, Combination; D019317:Evidence-Based Medicine; D006801:Humans; D010975:Platelet Aggregation Inhibitors / Q000009:adverse effects* / Q000493:pharmacokinetics / Q000627:therapeutic use; D054328:Proton Pump Inhibitors / Q000009:adverse effects* / Q000493:pharmacokinetics / Q000627:therapeutic use; D012307:Risk Factors; D013988:Ticlopidine / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000493:pharmacokinetics / Q000627:therapeutic use
D010975:Platelet Aggregation Inhibitors; D054328:Proton Pump Inhibitors; D000077144:Clopidogrel; D013988:Ticlopidine